Characteristic assay of incorporation of carbonated hydroxyapatite–propolis as an alternative for alveolar bone loss therapy on periodontitis: An in vitro study

Dual functional carbonate-hydroxyapatite nanocomposite from Pinctada maxima and egg-white for bone tissue engineering

This study aims to design a 3D carbonate-hydroxyapatite (CHA)/sago (S) based egg white (EW) microstructure with antibacterial properties to improve the performance of bone grafts for bone tissue engineering. In this study, Pinctada maxima (P. maxima) shell was used as a calcium (Ca) source in CHA synthesis. The annealing temperature of CHA at 900, 1000, and 1100 °C affected microstructural and lattice parameters, with stoichiometry 1.72-1.77, and B-type CHA was identified. CHA/S with various concentrations of EW (10 and 30 wt.%) effectively increased pore size and porosity. XRD spectra confirmed that sago and EW in CHA nanocomposite stable the crystal structure. FTIR spectrum shows protein phosphorylation in CHA nanocomposite due to PO₄^3- ion exchange. In-vitro bioactivity of CHA-S10 (MTT assay) showed increased cell viability and optical density (OD; 24-48 h) to control. Antibacterial activity of CHA-S10 and CHA/S (control) against bacteria associated with periodontal disease and bone infection (Actinobacillus actinomycetemcomitans [A. actinomycetemcomitans], Porphyromonas gingivalis [P. gingivalis], Fusobacterium nucleatum [F. nucleatum; gram negative], and Staphylococcus aureus [S. aureus; gram positive]) by disc diffusion method showed that CHA-S10 and CHA/S had strong antibacterial activity. In conclusion, EW's properties had proven the CHA/S/EW as bone grafts, effectively increasing pore size, porosity, biocompatibility, and strong antibacterial properties.